Specific Thrombin Inhibitors in Vivo
- 1 April 1994
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 714 (1), 41-52
- https://doi.org/10.1111/j.1749-6632.1994.tb12029.x
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseThe American Journal of Cardiology, 1993
- Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutterJournal of the American College of Cardiology, 1992
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- The Structure of a Complex of Recombinant Hirudin and Human α-ThrombinScience, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.Stroke, 1988
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.Journal of Clinical Investigation, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1980